
CDC Identifies Four Urgent Threats Among 19 Drug-Resistant Germs
What Happened?
The CDC's 2026 report highlights 19 drug-resistant pathogens, with four classified as urgent threats, causing an estimated 50,800 deaths annually in the US.
Key points
- The CDC estimates 9.7 million infections and 50,800 deaths from drug-resistant pathogens annually in the US.
- Four urgent threats include Candida auris, carbapenem-resistant Acinetobacter, carbapenem-resistant Enterobacterales, and drug-resistant Neisseria gonorrhoeae.
- Drug-resistant gonorrhoea accounted for approximately 787,000 infections in 2023.
- C. diff has moved from urgent to serious threat due to successful infection prevention in healthcare settings.
- New entries on the serious threat list include drug-resistant Neisseria meningitidis.
Key insights
- The classification of pathogens helps prioritize public health responses.
- Increased awareness of drug-resistant infections may lead to better prevention strategies.
- Healthcare facilities may need to enhance infection control measures to address these threats.
Why it matters
Understanding these threats is crucial for public health and infection control efforts.
Source
Times Now